Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17084512rdf:typepubmed:Citationlld:pubmed
pubmed-article:17084512lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0015133lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C1522484lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0036525lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0231174lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C1317973lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0183683lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0344211lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C1521721lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C1518411lld:lifeskim
pubmed-article:17084512lifeskim:mentionsumls-concept:C1171411lld:lifeskim
pubmed-article:17084512pubmed:issue3lld:pubmed
pubmed-article:17084512pubmed:dateCreated2007-1-22lld:pubmed
pubmed-article:17084512pubmed:abstractTextTo assess the impact on survival of high-dose chemotherapy with haematopoietic support in patients with high-volume, metastatic nonseminomatous germ cell tumours.lld:pubmed
pubmed-article:17084512pubmed:languageenglld:pubmed
pubmed-article:17084512pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17084512pubmed:citationSubsetIMlld:pubmed
pubmed-article:17084512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17084512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17084512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17084512pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17084512pubmed:statusMEDLINElld:pubmed
pubmed-article:17084512pubmed:monthMarlld:pubmed
pubmed-article:17084512pubmed:issn0302-2838lld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:CulineStéphan...lld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:BironPierrePlld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:DrozJean-Pier...lld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:ChevreauChris...lld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:CuréHervéHlld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:KramarAndrewAlld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:KerbratPierre...lld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:ThéodoreChris...lld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:BouzyJeannine...lld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:PicoJosé-Luis...lld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:PényJeanJlld:pubmed
pubmed-article:17084512pubmed:authorpubmed-author:Genito-Urinar...lld:pubmed
pubmed-article:17084512pubmed:issnTypePrintlld:pubmed
pubmed-article:17084512pubmed:volume51lld:pubmed
pubmed-article:17084512pubmed:ownerNLMlld:pubmed
pubmed-article:17084512pubmed:authorsCompleteYlld:pubmed
pubmed-article:17084512pubmed:pagination739-46; discussion 747-8lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:meshHeadingpubmed-meshheading:17084512...lld:pubmed
pubmed-article:17084512pubmed:year2007lld:pubmed
pubmed-article:17084512pubmed:articleTitleFailure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.lld:pubmed
pubmed-article:17084512pubmed:affiliationCentre Léon Bérard, Lyon, France.lld:pubmed
pubmed-article:17084512pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17084512pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:17084512pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17084512pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17084512lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17084512lld:pubmed